 | G1 Therapeutics, Inc. | |||
| NMS : GTHX || Location: United States | ||||
$3.86-0.13 (-3.26%) |
0.54 M | 3.77 - 3.93 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.422 M |
| March 28, 2024 | 2.757 M |
| March 15, 2024 | 2.695 M |
| Feb. 29, 2024 | 2.912 M |
| Feb. 15, 2024 | 3.326 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.28 | -0.21 | 25.19% |
| 09/30/2023 | -0.34 | -0.35 | -4.29% |
| 06/30/2023 | -0.22 | 0.14 | 162.75% |
| 03/31/2023 | -0.65 | -0.53 | 18.81% |
| 12/31/2022 | -0.86 | -0.73 | 15.21% |
GTHX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 52.199M | Shares Float | 43.589M |
| Short Float | 2.422M | Market Cap | 201.49M |
| Institution ownership | 30.58% | Insider ownership | 11.678% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.93 | Forward EPS | -0.45 |